RCGHX Virtus KAR Health Sciences C Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), ZOETIS (NYSE:ZTS).

The investment seeks long-term capital appreciation. The fund seeks to achieve its objective by normally investing at least 80% of its net assets (plus borrowings made for investment purposes) in health sciences-related companies. The portfolio manager considers health sciences-related companies to include companies that design, manufacture or sell products or services used for or in connection with healthcare, medicine or life sciences. The fund will invest primarily in common stocks and other equity securities.

The average market capitalization across the Virtus KAR Health Sciences C MF is 232.55B. The market cap for tickers in the group ranges from 19.72B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is COO at 19.72B.

The average weekly volume growth across all stocks in the Virtus KAR Health Sciences C MF was 37%. For the same stocks of the MF, the average monthly volume growth was -4% and the average quarterly volume growth was 87%